Breaking News Instant updates and real-time market news.

CANF

Can-Fite BioPharma

$2.04 /

-0.02 (-0.97%)

07:20
06/04/20
06/04
07:20
06/04/20
07:20

Can-Fite BioPharma concludes meeting with EMA on Phase 3 Namodenoson development

Can-Fite BioPharma announced it has concluded a meeting with the Scientific Advice Working Party, or SAWP, of the European Medicines Agency, or EMA, regarding Phase III development of its drug candidate Namodenoson in the treatment of hepatocellular carcinoma, or HCC, the most common form of liver cancer. Namodenoson is Can-Fite's adenosine A3 receptor, or A3AR, agonist which has recently been shown to prolong median overall survival, or OS, in a selected patient population with HCC in a Phase II clinical trial. Can-Fite sought scientific advice from the EMA to complement previous input from the FDA in its recent end-of-Phase II meeting regarding plans for a Phase III registration trial of Namodenoson in patients with HCC and Child Pugh Class B7, or CPB7 cirrhosis. Having completed its meeting with the SAWP, Can-Fite now has sufficient regulatory input to conduct a registration trial in accordance with the requirements of both the U.S. and the European Union. The planned trial, a randomized, double blind, placebo controlled trial, will enroll approximately 450 patients with HCC and underlying CPB7 cirrhosis at multiple centers worldwide. Patients will be randomized to oral treatment with either Namodenoson 25 mg or matching placebo given twice daily. The primary efficacy endpoint of the trial is overall survival, or OS, based on the favorable OS response seen in the Phase II trial in patients with HCC and CPB7 cirrhosis. Other oncology trial efficacy outcomes, such as tumor radiographic response rates and median progression-free survival, as well as standard safety parameters, will be assessed.

  • 04

    Jun

CANF Can-Fite BioPharma
$2.04 /

-0.02 (-0.97%)

10/31/19 H.C. Wainwright
Can-Fite BioPharma price target raised to $5 from $3 at H.C. Wainwright

TODAY'S FREE FLY STORIES

Upgrade
Coca-Cola European Partners upgraded to Buy from Hold at ABN Amro » 05:20
07/06/20
07/06
05:20
07/06/20
05:20
CCEP

Coca-Cola European Partners

$38.06 /

+0.3 (+0.79%)

ABN Amro analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CCEP Coca-Cola European Partners
$38.06 /

+0.3 (+0.79%)

CCEP Coca-Cola European Partners
$38.06 /

+0.3 (+0.79%)

06/22/20 Citi
Citi calls Coca-Cola European Partners its Top Pick in Beverages
06/10/20 ABN Amro
Coca-Cola European Partners upgraded to Hold from Sell at ABN Amro
06/05/20 HSBC
Coca-Cola European Partners initiated with a Hold at HSBC
06/01/20 Societe Generale
Coca-Cola European Partners initiated with a Sell at Societe Generale
CCEP Coca-Cola European Partners
$38.06 /

+0.3 (+0.79%)

Downgrade
Cooper Companies downgraded to Neutral from Outperform at Baird » 05:19
07/06/20
07/06
05:19
07/06/20
05:19
COO

Cooper Companies

$288.84 /

+1.505 (+0.52%)

Baird analyst Jeff…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COO Cooper Companies
$288.84 /

+1.505 (+0.52%)

COO Cooper Companies
$288.84 /

+1.505 (+0.52%)

06/05/20 UBS
UBS backs Buy on Alcon after Cooper results
05/26/20 Stephens
Cooper Companies price target raised to $325 from $300 at Stephens
05/26/20 KeyBanc
Cooper Companies price target lowered to $330 from $380 at KeyBanc
05/21/20 Wells Fargo
Cooper Companies price target lowered to $329 from $388 at Wells Fargo
COO Cooper Companies
$288.84 /

+1.505 (+0.52%)

COO Cooper Companies
$288.84 /

+1.505 (+0.52%)

Hot Stocks
Endologix commences voluntary Chapter 11 process  05:19
07/06/20
07/06
05:19
07/06/20
05:19
ELGX

Endologix

$0.78 /

-0.016 (-2.01%)

 
ShowHide Related Items >><<
ELGX Endologix
$0.78 /

-0.016 (-2.01%)

ELGX Endologix
$0.78 /

-0.016 (-2.01%)

05/12/20 BTIG
Endologix downgraded to Neutral from Buy at BTIG
04/06/20 Piper Sandler
Endologix capital needs remain an overhang, says Piper Sandler
03/16/20 Piper Sandler
Piper says Endologix FDA approval positive, but capital needs remain an overhang
02/19/20 Piper Sandler
Endologix price target lowered to $1 from $3 at Piper Sandler
ELGX Endologix
$0.78 /

-0.016 (-2.01%)

Upgrade
AP Moller Maersk upgraded to Buy from Hold at Deutsche Bank » 05:19
07/06/20
07/06
05:19
07/06/20
05:19
AMKBY

AP Moller Maersk

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMKBY AP Moller Maersk
$0.00 /

+ (+0.00%)

07/02/20 Barclays
AP Moller Maersk price target raised to DKK 6,400 from DKK 6,100 at Barclays
06/01/20 JPMorgan
AP Moller Maersk upgraded to Overweight from Neutral at JPMorgan
05/29/20 Barclays
AP Moller Maersk price target lowered to DKK 6,100 from DKK 6,300 at Barclays
05/28/20 Berenberg
AP Moller Maersk downgraded to Sell from Hold at Berenberg
Hot Stocks
Air Products signs exclusive strategic cooperation agreement with thyssenkrupp » 05:17
07/06/20
07/06
05:17
07/06/20
05:17
APD

Air Products

$247.27 /

+3.52 (+1.44%)

Air Products and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APD Air Products
$247.27 /

+3.52 (+1.44%)

APD Air Products
$247.27 /

+3.52 (+1.44%)

06/16/20
Fly Intel: Top five analyst downgrades
06/16/20 HSBC
Air Products downgraded to Hold on cyclicality, valuation at HSBC
06/16/20 HSBC
Air Products downgraded to Hold from Buy at HSBC
04/24/20 JPMorgan
Air Products price target raised to $242 from $237 at JPMorgan
APD Air Products
$247.27 /

+3.52 (+1.44%)

APD Air Products
$247.27 /

+3.52 (+1.44%)

APD Air Products
$247.27 /

+3.52 (+1.44%)

Downgrade
Spotify downgraded to Underperform from Market Perform at Bernstein » 05:17
07/06/20
07/06
05:17
07/06/20
05:17
SPOT

Spotify

$271.59 /

+12.63 (+4.88%)

Bernstein analyst Todd…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPOT Spotify
$271.59 /

+12.63 (+4.88%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

07/01/20 Wells Fargo
Spotify price target raised to $175 from $130 at Wells Fargo
06/30/20 Citi
Spotify initiated with a Neutral at Citi
06/29/20
Fly Intel: Top five analyst downgrades
06/29/20 Guggenheim
Guggenheim cuts Spotify to Sell with potential podcast dominance priced in
SPOT Spotify
$271.59 /

+12.63 (+4.88%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

Downgrade
BHP Group downgraded to Neutral from Outperform at Credit Suisse » 05:16
07/06/20
07/06
05:16
07/06/20
05:16
BHP

BHP Group

$50.07 /

+0.625 (+1.26%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHP BHP Group
$50.07 /

+0.625 (+1.26%)

BHP BHP Group
$50.07 /

+0.625 (+1.26%)

07/01/20 Deutsche Bank
BHP Group downgraded to Hold on decarbonization risk at Deutsche Bank
07/01/20 Deutsche Bank
BHP Group downgraded to Hold from Buy at Deutsche Bank
06/25/20 UBS
BHP Group price target raised to 1,850 GBp from 1,700 GBp at UBS
06/08/20 JPMorgan
BHP Group price target raised to 1,830 GBp from 1,780 GBp at JPMorgan
BHP BHP Group
$50.07 /

+0.625 (+1.26%)

BHP BHP Group
$50.07 /

+0.625 (+1.26%)

Upgrade
Close Brothers upgraded to Hold from Sell at Canaccord » 05:15
07/06/20
07/06
05:15
07/06/20
05:15
CBGPY

Close Brothers

$0.00 /

+ (+0.00%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBGPY Close Brothers
$0.00 /

+ (+0.00%)

07/01/20 RBC Capital
Close Brothers upgraded to Outperform from Sector Perform at RBC Capital
05/27/20 Investec
Close Brothers downgraded to Sell from Hold at Investec
04/27/20 Jefferies
Close Brothers downgraded to Underperform from Hold at Jefferies
04/24/20 JPMorgan
Close Brothers price target lowered to 1,170 GBp from 1,550 GBp at JPMorgan
Downgrade
Elior Group downgraded to Sell from Neutral at Bryan Garnier » 05:14
07/06/20
07/06
05:14
07/06/20
05:14
ELROF

Elior Group

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELROF Elior Group
$0.00 /

+ (+0.00%)

05/12/20 JPMorgan
Elior Group downgraded to Neutral from Overweight at JPMorgan
05/06/20 Deutsche Bank
Elior Group price target lowered to EUR 7.30 from EUR 7.50 at Deutsche Bank
04/30/20 Deutsche Bank
Elior Group price target lowered to EUR 7.50 from EUR 7.60 at Deutsche Bank
04/16/20 JPMorgan
Elior Group price target lowered to EUR 10 from EUR 13.60 at JPMorgan
Downgrade
Software AG downgraded to Sell from Neutral at Bryan Garnier » 05:11
07/06/20
07/06
05:11
07/06/20
05:11
STWRY

Software AG

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STWRY Software AG
$0.00 /

+ (+0.00%)

07/03/20 DZ Bank
Software AG downgraded to Hold from Buy at DZ Bank
06/02/20 Morgan Stanley
Software AG price target raised to EUR 30 from EUR 28 at Morgan Stanley
04/28/20 Morgan Stanley
Software AG downgraded to Equal Weight from Overweight at Morgan Stanley
03/11/20 Morgan Stanley
Software AG upgraded to Overweight from Equal Weight at Morgan Stanley
Downgrade
Temenos downgraded to Sell from Neutral at Bryan Garnier » 05:10
07/06/20
07/06
05:10
07/06/20
05:10
TMSNY

Temenos

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TMSNY Temenos
$0.00 /

+ (+0.00%)

06/09/20 Citi
Temenos downgraded to Neutral from Buy at Citi
06/01/20 Deutsche Bank
Temenos downgraded to Hold from Buy at Deutsche Bank
05/29/20 JPMorgan
Temenos downgraded to Neutral from Overweight at JPMorgan
04/15/20 Barclays
Temenos price target lowered to CHF 109 from CHF 147 at Barclays
TMSNY Temenos
$0.00 /

+ (+0.00%)

Recommendations
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler » 05:02
07/06/20
07/06
05:02
07/06/20
05:02
BHVN

Biohaven Pharmaceutical

$71.19 /

-1.075 (-1.49%)

, ABBV

AbbVie

$98.87 /

-0.25 (-0.25%)

Per Iqvia, the latest…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

06/25/20 Mizuho
Biohaven selloff yesterday a buying opportunity, says Mizuho
06/24/20 Piper Sandler
Piper Sandler stays Overweight Biohaven after troriluzole efficacy signal in OCD
06/23/20 Cantor Fitzgerald
Biohaven Pharmaceutical price target raised to $109 from $82 at Cantor Fitzgerald
06/19/20 Piper Sandler
Biohaven launch of Nurtec continues to impress, says Piper Sandler
ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
06/25/20 RBC Capital
AbbVie price target raised to $125 from $102 at RBC Capital
06/24/20 BofA
AbbVie Orilissa guidance for 2025 in more jeopardy after Myovant data, says BofA
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

  • 29
    Jan
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

Downgrade
Netflix downgraded to In-Line from Outperform at Imperial Capital » 04:58
07/06/20
07/06
04:58
07/06/20
04:58
NFLX

Netflix

$476.31 /

-9.47 (-1.95%)

Imperial Capital analyst…

Imperial Capital analyst David Miller downgraded Netflix to In-Line from Outperform with an unchanged price target of $489. The stock closed Thursday down $8.75 to $476.89. The shares are up over 50% since January 2, Miller tells investors in a research note. As a result, the analyst sees only an additional 2.5% upside in Netflix. He cites valuation for the downgrade to In-Line.

ShowHide Related Items >><<
NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/30/20 Cowen
Netflix price target raised to $535 from $485 at Cowen
06/23/20 JPMorgan
Netflix user growth implies upside to Q2 guidance, says JPMorgan
06/18/20 Imperial Capital
Netflix price target raised to $489 from $485 at Imperial Capital
NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

Upgrade
Xilinx upgraded to Conviction Buy from Buy at Goldman Sachs » 04:56
07/06/20
07/06
04:56
07/06/20
04:56
XLNX

Xilinx

$95.29 /

+2.01 (+2.15%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

06/30/20 SunTrust
Xilinx price target raised to $104 from $93 at SunTrust
06/30/20 Susquehanna
Xilinx price target raised to $115 from $105 at Susquehanna
06/30/20 JPMorgan
Xilinx price target raised to $88 from $85 at JPMorgan
06/30/20 Morgan Stanley
Xilinx trends less negative than feared, says Morgan Stanley
XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

Conference/Events
Cantor Fitzgerald healthcare analysts to hold analyst/industry conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

Specialty Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS leisure, gaming & lodging analyst to hold analyst/industry conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

Leisure, Gaming &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Cloudera participates in a conference call with JMP Securities » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
CLDR

Cloudera

$12.28 /

-0.1 (-0.81%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

06/10/20 Morgan Stanley
Morgan Stanley says Cloudera could be valued at $14.50 using typical PE multiple
06/09/20 DA Davidson
DA Davidson says Cloudera sale 'increasingly likely,' IBM seen as possible buyer
06/09/20 Northland
Northland downgrades Cloudera to Market Perform as coverage transferred
06/03/20
Fly Intel: Top five analyst upgrades
CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

Conference/Events
NetApp management to meet virtually with Oppenheimer » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
NTAP

NetApp

$43.57 /

+0.08 (+0.18%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTAP NetApp
$43.57 /

+0.08 (+0.18%)

NTAP NetApp
$43.57 /

+0.08 (+0.18%)

06/26/20
Fly Intel: Top five analyst upgrades
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/18/20 Deutsche Bank
NetApp initiated with a Hold at Deutsche Bank
NTAP NetApp
$43.57 /

+0.08 (+0.18%)

NTAP NetApp
$43.57 /

+0.08 (+0.18%)

NTAP NetApp
$43.57 /

+0.08 (+0.18%)

NTAP NetApp
$43.57 /

+0.08 (+0.18%)

General news
3-Month Bill Auction to be released at 11:30  04:55
07/06/20
07/06
04:55
07/06/20
04:55
 
General news
PMI Services Index Level to be reported at 09:45 » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

June PMI Services Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Biohaven Pharmaceutical management to meet virtually with Piper Sandler » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
BHVN

Biohaven Pharmaceutical

$71.19 /

-1.075 (-1.49%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

06/25/20 Mizuho
Biohaven selloff yesterday a buying opportunity, says Mizuho
06/24/20 Piper Sandler
Piper Sandler stays Overweight Biohaven after troriluzole efficacy signal in OCD
06/23/20 Cantor Fitzgerald
Biohaven Pharmaceutical price target raised to $109 from $82 at Cantor Fitzgerald
06/19/20 Piper Sandler
Biohaven launch of Nurtec continues to impress, says Piper Sandler
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

  • 29
    Jan
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

Conference/Events
Hudson Pacific management to meet virtually with Piper Sandler » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
HPP

Hudson Pacific

$25.32 /

+0.03 (+0.12%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

06/26/20 Mizuho
Hudson Pacific shares could be worth $32-$40 with spinoff, says Mizuho
06/25/20
Fly Intel: Top five analyst downgrades
06/24/20 Morgan Stanley
Hudson Pacific cut to Equal Weight from Overweight at Morgan Stanley
04/16/20 Jefferies
Hudson Pacific initiated with a Hold at Jefferies
HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

General news
PMI Services Index Composite to be reported at 09:45 » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

June PMI Services Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
ObsEva to host conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
OBSV

ObsEva

$6.15 /

+0.17 (+2.84%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

03/24/20 Wedbush
ObsEva price target lowered to $34 from $40 at Wedbush
03/05/20 Wedbush
ObsEva price target raised to $40 after pipeline update at Wedbush
03/05/20 Wedbush
ObsEva price target raised to $40 from $36 at Wedbush
12/19/19 H.C. Wainwright
ObsEva price target raised to $40 from $36 at H.C. Wainwright
OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

General news
ISM Non-Mfg Index Composite to be reported at 10:00 » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

June ISM Non-Mfg Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.